Aurinia Pharmaceuticals Inc (AUPH)

Nov 18, 2024

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis - Business Wire

Nov 18, 2024

Nov 18, 2024

Layoff Tracker: Gilead Sciences Will Lay Off 104 Employees at California HQ - BioSpace

Nov 18, 2024

Nov 17, 2024

(AUPH) Technical Pivots with Risk Controls - Stock Traders Daily

Nov 17, 2024

Nov 17, 2024

GSA Capital Partners LLP Sells 102,373 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Nov 17, 2024

Nov 15, 2024

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024 - sharewise

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC's Strategic Reduction in Aurinia Pharmace - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Aurinia to Participate in Jefferies London Healthcare Conference - sharewise

Nov 14, 2024

Nov 14, 2024

Aurinia Pharmaceuticals Engages at London Conference - TipRanks

Nov 14, 2024

Nov 14, 2024

Aurinia Pharmaceuticals director Karen Smith sells $44,181 in stock - Investing.com India

Nov 14, 2024

Nov 13, 2024

Aurinia Pharmaceuticals director Karen Smith sells $44,181 in stock By Investing.com - Investing.com Australia

Nov 13, 2024

Nov 12, 2024

Aurinia Pharmaceuticals director sells shares valued at $38,415 - Investing.com India

Nov 12, 2024

Nov 12, 2024

Aurinia Pharmaceuticals director sells shares valued at $38,415 By Investing.com - Investing.com Canada

Nov 12, 2024

Nov 12, 2024

Aurinia Pharmaceuticals (NASDAQ:AUPH) Upgraded at StockNews.com - Defense World

Nov 12, 2024

Nov 12, 2024

Aurinia Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 12, 2024

Nov 11, 2024

Aurinia offers slimmer profile after investor pressure - The Pharma Letter

Nov 11, 2024

Nov 11, 2024

Leerink Partnrs Issues Optimistic Estimate for AUPH Earnings - MarketBeat

Nov 11, 2024

Nov 09, 2024

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Nov 08, 2024

Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon (NASDAQ:AUPH) - Seeking Alpha

Nov 08, 2024

Nov 08, 2024

Aurinia slashes workforce by 45% to focus on lupus and autoimmune assets - Pharmaceutical Technology

Nov 08, 2024

Nov 08, 2024

Aurinia stock jumps 14% on Q3 earnings, restructuring announcement - MSN

Nov 08, 2024

Nov 07, 2024

Earnings call: Aurinia Pharmaceuticals announced a 24% increase in total net revenue - Investing.com

Nov 07, 2024

Nov 07, 2024

Aurinia Pharmaceuticals Inc (AUPH) Quarterly 10-Q Report - Quartz

Nov 07, 2024

Nov 07, 2024

Aurinia Pharmaceuticals Announces Restructuring - citybiz

Nov 07, 2024

Nov 07, 2024

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 11%Should You Buy? - MarketBeat

Nov 07, 2024

Nov 07, 2024

Aurinia: Q3 Earnings Snapshot - The Washington Post

Nov 07, 2024

Nov 07, 2024

Aurinia stock jumps 14% on Q3 earnings, restructuring announcement (NASDAQ:AUPH) - Seeking Alpha

Nov 07, 2024

Nov 07, 2024

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development - sharewise

Nov 07, 2024

Nov 07, 2024

Aurinia Pharmaceuticals (AUPH) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors - citybiz

Nov 07, 2024

Nov 07, 2024

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth - Business Wire

Nov 07, 2024

Nov 06, 2024

Long Term Trading Analysis for (AUPH) - Stock Traders Daily

Nov 06, 2024

Nov 02, 2024

Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) are in the red if they invested three years ago - Yahoo Finance

Nov 02, 2024

Oct 31, 2024

Aurinia Pharmaceuticals (AUPH) to Release Earnings on Thursday - MarketBeat

Oct 31, 2024

Oct 30, 2024

Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024 - The Bakersfield Californian

Oct 30, 2024

Oct 30, 2024

Axonis Therapeutics Announces $115 Million Series A Financing - Quantisnow

Oct 30, 2024

Oct 30, 2024

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) surges 5.9%; individual investors who own 51% shares profited along with institutions - Simply Wall St

Oct 30, 2024

Oct 16, 2024

Objective long/short (AUPH) Report - Stock Traders Daily

Oct 16, 2024

Oct 14, 2024

Oppenheimer Downgrades Aurinia Pharmaceuticals Inc (AUPH) to a Perform from an Outperform - Knox Daily

Oct 14, 2024

Oct 14, 2024

Adversity is less terrifying than hope: Aurinia Pharmaceuticals Inc (AUPH) - SETE News

Oct 14, 2024

Oct 12, 2024

AQR Capital Management LLC Takes Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Oct 12, 2024

Oct 12, 2024

AQR Capital Management LLC Buys Shares of 202,241 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Oct 12, 2024

Oct 12, 2024

Aurinia Pharmaceuticals spotlights lupus nephritis drug - Investing.com India

Oct 12, 2024

Oct 11, 2024

Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024 - BioSpace

Oct 11, 2024

Oct 11, 2024

Charting the Course: Aurinia Pharmaceuticals Inc’s AUPH Stock Prospects - The InvestChronicle

Oct 11, 2024

Oct 11, 2024

Aurinia Pharmaceuticals Showcases LUPKYNIS’s Impact at ASN 2024 - TipRanks

Oct 11, 2024

Oct 11, 2024

Aurinia Pharmaceuticals spotlights lupus nephritis drug By Investing.com - Investing.com UK

Oct 11, 2024